Shigella Bioconjugate Vaccine(LimmaTech Biologics)

N/A

Report date: 2024/07/29 20:00:43

Base Information

Drug NameShigella Bioconjugate Vaccine(LimmaTech Biologics)
Drug Alias NameShigella4V2Shigella-4V2
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesKenya
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLimmatech Biologics Ag
China Registration ClassN/A

Develop Information

Active CompaniesLimmatech Biologics Ag
Inactive CompaniesN/A
Active IndicationsDysentery, Bacillary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A